Skip to content

Cow Milk Fat Obesity pRevention Trial

Cow Milk Fat Obesity pRevention Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03914807
Acronym
CoMFORT
Enrollment
534
Registered
2019-04-16
Start date
2020-01-01
Completion date
2025-06-01
Last updated
2023-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Childhood

Keywords

milk, fat, cohort-embedded

Brief summary

Cow's milk is a dietary staple for children in North America. Though clinical guidelines suggest children transition from whole (3.25% fat) milk to reduced (1%) fat milk at age 2 years, recent epidemiological evidence supports a link between whole milk consumption and lower adiposity in children. The purpose of this trial is to determine which milk fat recommendation minimizes excess adiposity and optimizes child nutrition and development. CoMFORT will be a parallel group randomized controlled trial among children aged 2 to 4 years participating in the TARGet Kids! practice-based research network. Children will be randomized to receive one of two usual care nutritional recommendations: 1) a recommendation to consume whole milk, or 2) a recommendation to consume reduced (1%) fat milk. The primary outcome is Body Mass Index z-score (zBMI); secondary outcomes will be cognitive development (using the Ages and Stages Questionnaire), vitamin D stores (serum 25-hydroxyvitamin D), cardiometabolic health (glucose, hsCRP, non-HDL, LDL, triglyceride, HDL and total cholesterol, insulin, and diastolic and systolic blood pressure) and sugar sweetened beverage intake (measured by 24-hour dietary recall). Outcomes will be measured 24 months post-randomization and compared using ANCOVA, adjusting for baseline measures. This trial will contribute to nutrition policy for children in effort to reduce childhood obesity using a simple, inexpensive and scalable cow's milk fat intervention.

Interventions

OTHERWhole (3.25%) cow's milk recommendation

Children randomized to the whole milk recommendation will receive a recommendation a primary care recommendation to consume 500 mL of whole fat (3.25%) milk instead of transitioning to reduced fat (1%) milk at 2 years of age. The primary care physician will verbally make this recommendation during the recruitment well-child visit. Parents will also be reminded bi-monthly by phone calls made by a research assistant. Children in the whole milk recommendation group will be provided with the same age-appropriate nutritional recommendations as children in the reduced fat recommendation group as part of routine healthcare according to the Rourke Baby Record.

OTHERReduced (1%) fat milk

Children randomized to the reduced fat group will receive a primary care recommendation to transition from whole milk to 500 mL reduced fat (1%) milk daily once the child is two years of age (consistent with current guidelines). The physician will verbally make this recommendation during the recruitment well-child visit. Parents will also be reminded bi-monthly by phone calls made by a research assistant. Children who receive the reduced fat recommendation will be provided with the same age-appropriate nutritional recommendations as children who receive the whole fat recommendation as part of routine healthcare according to the Rourke Baby Record.

Sponsors

Unity Health Toronto
CollaboratorOTHER
The Hospital for Sick Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Superiority cohort embedded 2 arm pragmatic randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Months to 60 Months
Healthy volunteers
Yes

Inclusion criteria

* healthy by parental report; * 1.5 to 2.99 years of age * involved in a TARGet Kids! academic pediatric or family medicine group.

Exclusion criteria

* Prader-Willi syndrome or other syndrome associated with obesity * severe development delay * children who are from families without verbal communication in English or French * failure to thrive (with zBMI values ≤ -2 are unlikely to benefit from obesity prevention) * siblings of trial participants as families may share milk * will not consume cow's milk by choice, lactose intolerance or allergy.

Design outcomes

Primary

MeasureTime frameDescription
weightMeasured 24 months post-study entrykilograms; measured using a Healthometer stadiometer
heightMeasured 24 months post-study entrymetres; measured using a Healthometer statiometer
body mass index z-score (zBMI)Measured 24 months post-study entryBMI calculated by weight (kg)/height (m\^2); zBMI determined according to the World Health Organization guidelines

Secondary

MeasureTime frameDescription
blood pressuremeasured 24 months post-study entrysystolic and diastolic
serum insulinmeasured 24 months post-study entrymeasured in mmol/L
serum triglyceridesmeasured 24 months post-study entrymeasured in mmol/L
serum total cholesterolmeasured 24 months post-study entrymeasured in mmol/L
serum low density lipoprotein cholesterolmeasured 24 months post-study entrymeasured in mmol/L
serum non-high density lipoprotein cholesterolmeasured 24 months post-study entrymeasured in mmol/L
serum highly sensitive c-reactive proteinmeasured 24 months post-study entrymeasured in mg/L
height z-scoremeasured 24 months post-study entrymeasured by a trained research assistant according to the World Health Organization guidelines
waist circumferencemeasured 24 months post-study entrymeasured by a trained research assistant
lean body massmeasured 24 months post-study entrymeasured in kg, % body weight
fat massmeasured 24 months post-study entrymeasured in kg, % body weight
school readinessmeasured 24 months post-study entrymeasured using the Early Development Instrument (EDI); children scoring at or below the 25th percentile of children in their province are considered at risk for continuing on the low achievement and health trajectory, and are more likely to fall behind in academic achievement in later grades
serum high density lipoprotein cholesterolmeasured 24 months post-study entrymeasured in mmol/L
dietary intakemeasured 24 months post-study entrymeasured using the Automated Multiple Pass Self Administered 24 hour recall (ASA24) tool
carotid intima media thickness (cIMT)measured 24 months post-study entrymeasured by ultrasound
restrained and emotional eatingmeasured 24 months post-study entrymeasured using the 3-factor eating questionnaire
nutritional riskmeasured 24 months post-study entrymeasured using NutriSTEP preschooler
physical activity (minutes per day)measured 24 months post-study entryquestionnaire data and accelerometry
sleep time (hours per night)measured 24 months post-study entryquestionnaire data and accelerometry
healthcare service utilizationmeasured 24 months post-study entryinformation accessed through OHIP linkage
upper respiratory tract infection incidencemeasured 24 months post-study entryinformation accessed through OHIP linkage
growth trajectoriesmeasured 24 months post-study entryzBMI growth rates
head circumferencemeasured 24 months post-study entrymeasured by a trained research assistant
cost effectivenessmeasured 24 months post-study entryAll costs, parameter estimates and ranges will be derived from study data and will be obtained using medical record extraction. Publicly available Ontario costing sources will be used to cost resource utilisation parameters.
cognitive developmentmeasured 24 months post-study entrymeasured using the Ages and Stages Questionnaire (ASQ)
serum 25-hydroxyvitamin DMeasured 24 months post-study entrymeasured in nmol/L
serum glucosemeasured 24 months post-study entrymeasured in mmol/L

Countries

Canada

Contacts

Primary ContactJonathon L Maguire, MD, FRCPC
jonathon.maguire@utoronto.ca(416) 867-3655

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026